Key result
Analysis of 8 overexpressed and 7 underexpressed genes identified upregulation of MIP-1beta and downregulation of VE-cadherin in acute heart rejection across 41 murine and human samples.
Upregulation of MIP-1beta and downregulation of VE-cadherin are implicated in human acute heart transplant rejection.
Answers are grounded in this paper and cite their sources.
Murine rejection gene profiles may guide human biomarker discovery; leaves open clinical translation pending validation studies.
BACKGROUND: Genes and mechanisms of action involved in human acute rejection after allogeneic heart transplantation remain to be elucidated. The use of a murine allograft model in tandem with cDNA arrays and quantitative real-time polymerase chain reaction (Q-PCR) can greatly help in identifying key genes implicated in human heart acute rejection. METHODS AND RESULTS: Hearts from Balb/c mice were either not transplanted or transplanted heterotopically in the abdomen of Balb/c (isografts) and C57BL/6 (allografts) mice. Histological analysis showed acute rejection only in allografts. Total RNA was extracted from isografts (n=3), allografts (n=4), and not transplanted hearts (n=4); reverse transcribed; and labeled with P32. Each probe was hybridized to cDNA macroarrays. Eight genes were overexpressed and 7 genes were underexpressed in allografts compared with isografts. Macrophage inflammatory protein-1beta (MIP-1beta), an overexpressed gene, and VE-cadherin, an underexpressed gene, were validated by immunohistochemistry and Q-PCR in the murine models. Genes of interest, validated in the 3 murine groups, were then investigated in human heart tissues. Immunohistochemistry and Q-PCR performed on endomyocardial biopsies after heart transplantation showing no rejection (n=10) or grade IB (n=10) or IIIA (n=10) rejection, according to International Society of Heart and Lung Transplantation criteria, confirmed the results obtained from the murine model. CONCLUSIONS: We have demonstrated that the upregulation of MIP-1beta and downregulation of VE-cadherin may strongly participate in human acute heart rejection.
No takes yet. Share an insight, caveat, or question.
Roussoulières et al. (2005) studied Acute rejection after heart transplantation (n=41). Acute heart rejection vs. No rejection was evaluated on Gene expression of MIP-1beta and VE-cadherin. Analysis of 8 overexpressed and 7 underexpressed genes identified upregulation of MIP-1beta and downregulation of VE-cadherin in acute heart rejection across 41 murine and human samples.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: